Identification of Diagnostic and Prognostic Biomarkers in Nasopharyngeal Carcinoma Using Integrated Transcriptomics and Elastic Net Survival Analysis
Authors:
Open Access
- 23 August 2025
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Bioinformatics Journal
- Vol. 18 (1)
Abstract
Introduction: Nasopharyngeal carcinoma (NPC) is a malignant tumor with distinct molecular features, underscoring the need for reliable biomarkers to improve diagnosis, prognosis, and therapeutic strategies. Methods: We analyzed transcriptomic data from GEO datasets (GSE12452, GSE53819, and GSE102349) to identify diagnostic and prognostic biomarkers. Differential expression analysis was performed to detect potential markers, while survival analysis was conducted using Cox proportional hazards (Cox-PH) modeling and log-rank tests. Elastic Net regression was used to refine the gene signature. RNA-protein expression concordance was validated using the Cancer Cell Line Encyclopedia (CCLE) dataset. Results: Differential expression analysis revealed 591 genes as potential diagnostic markers. Survival analysis identified 54 genes with dual diagnostic and prognostic relevance. Elastic Net regression refined this to an 11-gene signature, which stratified patients into high- and low-risk groups, significantly predicting progression-free survival (log-rank p = 0.0035). Five genes (BUB1B, GAS2L3, NFE2L3, OIP5, and PDGFRL) were identified as potential oncogenic drivers, while six (CD1D, CYP4B1, IL33, KLF2, NAPSB, and VILL) were implicated as tumor suppressors. Six genes (BUB1B, GAS2L3, IL33, OIP5, PDGFRL, and VILL) showed strong RNA-protein expression concordance in the CCLE dataset. Discussion: This study reveals previously unreported cancer-associated genes (NAPSB, GAS2L3, NFE2L3, PDGFRL, CD1D, CYP4B1, KLF2) in NPC while validating established biomarkers (BUB1B, OIP5, IL33, VILL). Our findings expand NPC molecular characterization but require further clinical validation. Conclusion: This study presents a robust gene signature for NPC, offering valuable insights into tumor progression and providing a foundation for advancing diagnostic strategies, improving prognostic stratification, and developing targeted therapies.Keywords
This publication has 38 references indexed in Scilit:
- Molecular diagnosis of nasopharyngeal carcinoma: Past and futureBiomedical Journal, 2024
- The effect of interleukin-33 expression on prognosis in patients with nasopharyngeal carcinomaActa Otorrinolaringologica (English Edition), 2024
- Robust biomarker screening from gene expression data by stable machine learning-recursive feature elimination methodsComputational Biology and Chemistry, 2022
- The EEF1AKMT3/MAP2K7/TP53 axis suppresses tumor invasiveness and metastasis in gastric cancerCancer Letters, 2022
- Identification of key pathways and genes in nasopharyngeal carcinoma based on WGCNAAuris Nasus Larynx, 2022
- Deregulation of H19 is associated with cervical carcinomaGenomics, 2020
- Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmesBritish Journal of Cancer, 2019
- A Tumor Suppressor Gene Product, Platelet‐Derived Growth Factor Receptor‐Like Protein Controls Chondrocyte Proliferation and DifferentiationJournal of Cellular Biochemistry, 2017
- Gas2l3 is essential for brain morphogenesis and developmentDevelopmental Biology, 2014
- Human papillomavirus and Epstein–Barr virus in nasopharyngeal carcinoma in a low‐incidence populationHead & Neck, 2013